Home / Health / N.L. Expands RSV Vaccine to All Infants and Seniors
N.L. Expands RSV Vaccine to All Infants and Seniors
27 Apr
Summary
- Newfoundland and Labrador now offers RSV vaccine to infants and seniors.
- The province aims to protect vulnerable populations from severe RSV illness.
- Universal infant access to RSV vaccine is expected by fall.
Newfoundland and Labrador is broadening access to the respiratory syncytial virus (RSV) vaccine. The province announced expanded eligibility to include infants up to six months old and individuals aged 75 and above. This initiative aims to safeguard populations most at risk of severe health complications from RSV, which can be particularly dangerous for very young children and seniors.
The provincial government highlighted this expansion as a key part of its health-care strategy. Health Minister Evans emphasized the importance of protecting vulnerable groups, noting that while RSV may present as a mild cold for many, it can be life-threatening for others. The National Advisory Committee on Immunization has recommended a universal RSV immunization program for all infants.
Newfoundland and Labrador's Chief Medical Officer of Health, Dr. Janice Fitzgerald, stated that RSV is highly common, with most children infected by age two. She added that for some, infection can lead to emergency room visits or intensive care. Fitzgerald confirmed that details for the program's rollout are being finalized, with an expected launch in the fall. The vaccine will be administered to babies before they leave the hospital or shortly after birth.
